[The "Fifteenth Five-Year Plan for the Development of the Pharmaceutical Industry" was released. The average annual growth rate of the innovative drug industry will exceed 20%] On September 18, ten departments including the Ministry of Industry and Information Technology, the National Development and Reform Commission, the Ministry of Natural Resources, the Ministry of Agriculture and Rural Affairs, the Ministry of Commerce, the National Health Commission, the Ministry of Emergency Management, the National Medical Insurance Administration, the State Administration of Traditional Chinese Medicine, and the State Food and Drug Administration jointly released the "Fifteenth Five-Year Plan for the Development of the Pharmaceutical Industry" (hereinafter referred to as the "Plan"). The "Plan" proposes development goals by 2030: biomedical R&D and application will remain at the forefront of the world, innovation-driven efficiency will be fully unleashed, key core technologies in key areas will achieve systematic breakthroughs, and the biomedical industry will accelerate to become the country's emerging pillar industry. At the same time, the "Plan" puts forward 10 expected indicators such as the operating income of pharmaceutical industry enterprises above designated size, the intensity of R&D investment, the number of innovative pharmaceutical devices on the market, the cultivation of leading enterprises and hundreds of billions of parks, focusing on industrial scale benefits, innovative development, enterprise cultivation and cluster development.